2023 Was a tough calendar year with the biopharma marketplace, with many companies downsizing and restructuring their workforces to remain afloat. You'll find indications of recovery, as mergers and acquisitions picked up throughout the pharmaceutical and existence sciences business within the latter part of 2023 and also have ongoing their https://sites.google.com/view/bio-sites/blog